Technavio, a tech-focused market research firm, has published a new report on the global veterinary vaccines market, which is expected to grow at a CAGR of close to 5% during the forecast period 2017-2021.
Based on geographical segmentation, Technavio market researchers categorize the global veterinary vaccines market into the following key regions: the Americas, APAC, and EMEA.
Source: Technavio
Click here to request a free sample of this report
Top three contributors for the global veterinary vaccines market are elaborated below
Veterinary vaccines market in Americas: Growing husbandry practices and improved farm management are the fundamental driving forces behind growth of the veterinary vaccines market in the Americas. Furthermore, a majority of countries provide insurance for pet vaccinations, which results in the growth of companion animal vaccinations.
According to Barath Palada, a lead analyst at Technavio, specializing in research on infectious and rare diseases, “The technological advances in the last few years such as the growing usage of continuous cell lines as substrate and the approval of fermenter technology for antigen productions by USDA are helping in further consolidation of the vaccine market in the region. Besides, the increase in inorganic strategies is helping the vendors increase their penetration in relatively untapped countries within the region.”
Veterinary vaccines market in EMEA: The growth of the veterinary vaccines market in EMEA is driven by factors such as the growing prevalence of animal infections and diseases, increasing awareness of antibiotic resistance, and various initiatives by the government and animal associations. During the forecast period, the market is expected to grow despite the challenges because of newer regulations in animal vaccines manufacturing. Furthermore, limitations on antibiotic usage will compel the animal owners to choose vaccines as a remedy to keep the animals healthy, thereby, driving the market growth.
Veterinary vaccines market in APAC: The market for veterinary vaccines in APAC is still in its growth phase. China, Australia, Japan, and India are the key revenue contributors in the overall animal vaccines market in the APAC region. Livestock handlers are getting more aware of food safety and have started using preventive mechanisms such as vaccines, thereby driving market growth.
The leading vendors operating in the global veterinary vaccines market are:
- Elanco
- Merck
- Merial
- Zoetis
Other prominent vendors in the market include Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac.
A more detailed analysis is available in the Technavio report titled, ‘Global Veterinary Vaccines Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Orphan Drugs Market 2017-2021
- Global Bovine Respiratory Disease Treatment 2017-2021
- Global Animal Parasiticides Market 2017-2021
To read more press releases – click here
